This study investigates the use of acupuncture for treating peripheral neuropathy in patients with gastrointestinal cancer. Peripheral neuropathy is a common issue for those who have had chemotherapy with oxaliplatin, a drug used in cancer treatment.
The study evaluates how acupuncture affects symptoms of peripheral neuropathy in these patients. Researchers are interested in understanding the safety and effectiveness of acupuncture as a treatment option.
- Who can participate: Adults aged 18 and older with gastrointestinal solid tumors who have undergone oxaliplatin-based chemotherapy and have a neuropathy score of 4 or higher can participate. Participants must understand French and be part of a national health care system.
- Study details: Participants will receive acupuncture from a trained physician acupuncturist. If receiving chemotherapy during the study, acupuncture will be provided concurrently.
How understandable was the trial content above?
Hard to understand
Easy to understand